发明名称 Implantable device for controlled dissolution and diffusion of low solubility drug
摘要 Implantable drug delivery devices are provided that are deformable between a relatively straightened shape suitable for deployment and a retention shape suited to retain the device within the bladder or other body cavity. While in the body cavity, the devices release drug from solid drug units housed in the devices. The devices are designed to house the solid drug units in a way that exposes one or more sides of the solid drug units to the fluid at the in vivo site of deployment. Methods for using the devices for administering drug and making the devices also are provided.
申请公布号 US9107816(B2) 申请公布日期 2015.08.18
申请号 US201213366981 申请日期 2012.02.06
申请人 TARIS BIOMEDICAL LLC 发明人 Lee Heejin;Duc Hong Linh Ho;Sansone Matthew
分类号 A61M31/00;A61K9/00;A61K31/337;A61K31/407;A61K31/46;A61K31/555;A61K31/7064;A61K33/24;A61M37/00 主分类号 A61M31/00
代理机构 Sutherland Asbill & Brennan LLP 代理人 Sutherland Asbill & Brennan LLP
主权项 1. An implantable drug delivery device comprising: a drug housing portion which comprises at least one solid drug unit comprising a drug, andat least one housing having at least one defined opening, wherein the at least one solid drug unit is located within the defined opening such that the housing encases a first portion of the surface of the at least one solid drug unit and exposes a second portion of the surface of the at least one solid drug unit, wherein the device is elastically deformable between a relatively straightened shape suited for insertion through a lumen into a body cavity of a patient and a retention shape suited to retain the device within the body cavity, and wherein release of the drug from the device is controlled by erosion of the exposed second portion of the surface of the at least one solid drug unit.
地址 Lexington MA US